Rybojad M - Search Results

1

High-dose recombinant interleukin-2 in advanced cutaneous T-cell lymphoma.

Marolleau JP, Baccard M, Flageul B, Rybojad M, Laroche L, Vérola O, Brandely M, Morel P, Gisselbrecht C. Marolleau JP, et al. Among authors: rybojad m. Arch Dermatol. 1995 May;131(5):574-9. Arch Dermatol. 1995. PMID: 7741545

2

Successful interleukin-2 therapy of advanced cutaneous T-cell lymphoma.

Rybojad M, Marolleau JP, Flageul B, Baccard M, Brandely M, Morel P, Gisselbrecht C. Rybojad M, et al. Br J Dermatol. 1992 Jul;127(1):63-4. doi: 10.1111/j.1365-2133.1992.tb14832.x. Br J Dermatol. 1992. PMID: 1637699 No abstract available.

3

Cutaneous lymphomas of the T cell type presenting primary tumors.

Carlotti A, Dallot A, Laroche L, Rybojad M, Feyeux C, Verola O, Gisselbrecht C, Morel P, Puissant A. Carlotti A, et al. Among authors: rybojad m. Curr Probl Dermatol. 1990;19:157-60. doi: 10.1159/000418086. Curr Probl Dermatol. 1990. PMID: 2298033 No abstract available.

4

Long-term follow-up of non-HIV Kaposi's sarcoma treated with low-dose recombinant interferon alfa-2b.

Costa da Cunha CS, Lebbe C, Rybojad M, Agbalika F, Ferchal F, Rabian C, Vignon-Pennamen MD, Calvo F, Morel P. Costa da Cunha CS, et al. Among authors: rybojad m. Arch Dermatol. 1996 Mar;132(3):285-90. doi: 10.1001/archderm.132.3.285. Arch Dermatol. 1996. PMID: 8607632

5

[Bone marrow autograft in the treatment of cutaneous lymphoma].

Zeitoun C, Baccard M, Marolleau JP, Rybojad M, Baruchel A, Morel P, Brice P. Zeitoun C, et al. Among authors: rybojad m. Ann Dermatol Venereol. 1996;123(2):79-84. Ann Dermatol Venereol. 1996. PMID: 8761756 French.

6

Middle-term evolution of patients with advanced cutaneous T-cell lymphoma treated with high-dose recombinant interleukin-2.

Baccard M, Marolleau JP, Rybojad M. Baccard M, et al. Among authors: rybojad m. Arch Dermatol. 1997 May;133(5):656. doi: 10.1001/archderm.1997.03890410120021. Arch Dermatol. 1997. PMID: 9158425 No abstract available.

7

[Aggressive cutaneous T-cell lymphoma associated with the presence of Epstein-Barr virus. 2 cases].

Mouly F, Baccard M, Rybojad M, Lebbé C, Morinet F, Morel P. Mouly F, et al. Among authors: rybojad m. Ann Dermatol Venereol. 1996;123(9):574-6. Ann Dermatol Venereol. 1996. PMID: 9615113 French.

8

Treatment of cutaneous sarcoidosis with thalidomide.

Nguyen YT, Dupuy A, Cordoliani F, Vignon-Pennamen MD, Lebbé C, Morel P, Rybojad M. Nguyen YT, et al. Among authors: rybojad m. J Am Acad Dermatol. 2004 Feb;50(2):235-41. doi: 10.1016/j.jaad.2003.07.006. J Am Acad Dermatol. 2004. PMID: 14726878 Clinical Trial.

9

Prognostic value of blood eosinophilia in primary cutaneous T-cell lymphomas.

Tancrède-Bohin E, Ionescu MA, de La Salmonière P, Dupuy A, Rivet J, Rybojad M, Dubertret L, Bachelez H, Lebbé C, Morel P. Tancrède-Bohin E, et al. Among authors: rybojad m. Arch Dermatol. 2004 Sep;140(9):1057-61. doi: 10.1001/archderm.140.9.1057. Arch Dermatol. 2004. PMID: 15381544

10

Chronic recurrent lymphocytic Sweet syndrome as a predictive marker of myelodysplasia: a report of 9 cases.

Vignon-Pennamen MD, Juillard C, Rybojad M, Wallach D, Daniel MT, Morel P, Verola O, Janin A. Vignon-Pennamen MD, et al. Among authors: rybojad m. Arch Dermatol. 2006 Sep;142(9):1170-6. doi: 10.1001/archderm.142.9.1170. Arch Dermatol. 2006. PMID: 16983004

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

185 results

Search Page

Filters